These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24709374)

  • 1. Gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation-related primary immunodeficiency is associated with disseminated mucormycosis.
    Kumar N; Hanks ME; Chandrasekaran P; Davis BC; Hsu AP; Van Wagoner NJ; Merlin JS; Spalding C; La Hoz RM; Holland SM; Zerbe CS; Sampaio EP
    J Allergy Clin Immunol; 2014 Jul; 134(1):236-9. PubMed ID: 24709374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature.
    Zerbe CS; Marciano BE; Katial RK; Santos CB; Adamo N; Hsu AP; Hanks ME; Darnell DN; Quezado MM; Frein C; Barnhart LA; Anderson VL; Uzel G; Freeman AF; Lisco A; Nath A; Major EO; Sampaio EP; Holland SM
    Clin Infect Dis; 2016 Apr; 62(8):986-94. PubMed ID: 26743090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1).
    Meesilpavikkai K; Dik WA; Schrijver B; Nagtzaam NMA; Posthumus-van Sluijs SJ; van Hagen PM; Dalm VASH
    J Allergy Clin Immunol; 2018 Jul; 142(1):328-330.e2. PubMed ID: 29729898
    [No Abstract]   [Full Text] [Related]  

  • 4. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
    Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
    J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
    Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
    J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.
    Breuer O; Daum H; Cohen-Cymberknoh M; Unger S; Shoseyov D; Stepensky P; Keller B; Warnatz K; Kerem E
    Respir Med; 2017 May; 126():39-45. PubMed ID: 28427548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.
    Sampaio EP; Hsu AP; Pechacek J; Bax HI; Dias DL; Paulson ML; Chandrasekaran P; Rosen LB; Carvalho DS; Ding L; Vinh DC; Browne SK; Datta S; Milner JD; Kuhns DB; Long Priel DA; Sadat MA; Shiloh M; De Marco B; Alvares M; Gillman JW; Ramarathnam V; de la Morena M; Bezrodnik L; Moreira I; Uzel G; Johnson D; Spalding C; Zerbe CS; Wiley H; Greenberg DE; Hoover SE; Rosenzweig SD; Galgiani JN; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1624-34. PubMed ID: 23541320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducer and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.
    Consonni F; Dotta L; Todaro F; Vairo D; Badolato R
    Curr Opin Pediatr; 2017 Dec; 29(6):711-717. PubMed ID: 28914637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenic T387A missense mutation in the gene encoding signal transducer and activator of transcription 1 exhibits a differential gene expression profile.
    Staab J; Schwämmle T; Meyer T
    Mol Immunol; 2020 Dec; 128():79-88. PubMed ID: 33096415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.
    Forbes LR; Vogel TP; Cooper MA; Castro-Wagner J; Schussler E; Weinacht KG; Plant AS; Su HC; Allenspach EJ; Slatter M; Abinun M; Lilic D; Cunningham-Rundles C; Eckstein O; Olbrich P; Guillerman RP; Patel NC; Demirdag YY; Zerbe C; Freeman AF; Holland SM; Szabolcs P; Gennery A; Torgerson TR; Milner JD; Leiding JW
    J Allergy Clin Immunol; 2018 Nov; 142(5):1665-1669. PubMed ID: 30092289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
    Uzel G; Sampaio EP; Lawrence MG; Hsu AP; Hackett M; Dorsey MJ; Noel RJ; Verbsky JW; Freeman AF; Janssen E; Bonilla FA; Pechacek J; Chandrasekaran P; Browne SK; Agharahimi A; Gharib AM; Mannurita SC; Yim JJ; Gambineri E; Torgerson T; Tran DQ; Milner JD; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1611-23. PubMed ID: 23534974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
    Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
    Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation for monoallelic signal transducer and activator of transcription 1 deficiency.
    Grunebaum E; Kim VH; Somers GR; Shammas A; Roifman CM
    J Allergy Clin Immunol; 2016 Aug; 138(2):612-615.e1. PubMed ID: 27061251
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal combined immunodeficiency associated with heterozygous mutation in STAT1.
    Sharfe N; Nahum A; Newell A; Dadi H; Ngan B; Pereira SL; Herbrick JA; Roifman CM
    J Allergy Clin Immunol; 2014 Mar; 133(3):807-17. PubMed ID: 24239102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
    Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
    J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on gain-of-function mutations in primary immunodeficiency diseases.
    Jhamnani RD; Rosenzweig SD
    Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):391-397. PubMed ID: 29040208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosis.
    Camargo JF; Bhimji A; Kumar D; Kaul R; Pavan R; Schuh A; Seftel M; Lipton JH; Gupta V; Humar A; Husain S
    PLoS One; 2015; 10(4):e0123171. PubMed ID: 25835547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function.
    Sampaio EP; Ding L; Rose SR; Cruz P; Hsu AP; Kashyap A; Rosen LB; Smelkinson M; Tavella TA; Ferre EMN; Wierman MK; Zerbe CS; Lionakis MS; Holland SM
    J Allergy Clin Immunol; 2018 May; 141(5):1844-1853.e2. PubMed ID: 28859974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT1 gain-of-function and chronic demodicosis.
    Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
    Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel STAT1 mutation associated with disseminated mycobacterial disease.
    Sampaio EP; Bax HI; Hsu AP; Kristosturyan E; Pechacek J; Chandrasekaran P; Paulson ML; Dias DL; Spalding C; Uzel G; Ding L; McFarland E; Holland SM
    J Clin Immunol; 2012 Aug; 32(4):681-689. PubMed ID: 22437822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.